← Back to All Filings

Carlyle Group Entities Sell $1.07 Billion in Medline (MDLN) Stock

High SignificanceMarch 12, 2026 at 4:33:14 PM EDT

Medline Inc.

$MDLN4CIK: 0002046386

Subscribe to track MDLN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Carlyle Group Entities Sell $1.07 Billion in Medline (MDLN) Stock

Company: Medline Inc. (MDLN) Form: 4 | Filed: 2026/03/12 Significance: High

Insider: Carlyle Mozart Coinvestment Holdings, L.P. (The Carlyle Group) Relationship: 10% Owner

Transaction: • Type: Sell • Shares: 26,105,840 • Price: $41.00 • Value: $1,070,339,440 • Owned After: 125,454,241

Key Insight: Major private equity monetization event. The Carlyle Group entities sold approximately 1.99% of the total shares outstanding in a single day, generating over $1 billion in liquidity.

Market Context: This is a massive block sale representing nearly 1.86% of the company's total market capitalization.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Medline Inc. (MDLN)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The Carlyle Group executes a massive $1.07 billion partial exit, selling nearly 2% of the company's total outstanding shares.
  • Market Impact: High supply impact; likely negative short-term pressure unless executed via a pre-arranged block trade.

Company Information

FieldValue
CompanyMedline Inc.
Ticker SymbolMDLN
CIK0002046386
IndustrySurgical & Medical Instruments

Insider Information

FieldValue
NameCarlyle Mozart Coinvestment Holdings, L.P. (The Carlyle Group)
CIK0001878065
Relationship10% Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-10
Transaction CodeS (Open Market or Private Sale)
Security TypeClass A Common Stock
Shares Involved26,105,840
Price Per Share$41.00
Total Value$1,070,339,440
Shares Owned After125,454,241
Ownership TypeIndirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,070,339,440
% of Market Cap1.86%
Shares Transacted26,105,840
% of Shares Outstanding1.99%
Post-Transaction Ownership125,454,241 shares (9.55% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: For a $57.58 billion company, a $1 billion transaction is extremely large, far exceeding typical insider activity.
  • Ownership Concentration: Even after this massive sale, the reporting group retains a controlling-level stake of over 125 million shares (~9.5% of the company).
  • Transaction Significance: The sale represents nearly 2% of all shares outstanding. This is a major liquidity event that materially alters the float.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Negative
  • Reasoning: The introduction of $1 billion worth of stock supply typically creates price headwinds. While likely a negotiated block trade, it signals a desire by a major backer to reduce exposure.

Volume & Sentiment

  • Expected Volume Impact: Extreme. This transaction volume is likely multiples of the average daily trading volume.
  • Sentiment Indicator: Bearish. Large-scale PE exits can signal a perceived valuation peak or simply fund lifecycle maturity, but often weigh on sentiment.

Investment Insights

Risk Factors

  • Supply Overhang: With 125 million shares remaining, the market may fear future secondary offerings or block sales.
  • PE Exit Cycle: Private equity sponsors typically exit in stages; this may be the start of a broader unwinding of the position.

Key Takeaways

  1. Massive Liquidity Event: This is not a routine trim; it is a strategic monetization of over $1 billion.
  2. Continued Overhang: The Carlyle Group remains a massive holder, suggesting this stock will be influenced by their exit timeline for the foreseeable future.
  3. Pricing Benchmark: The $41.00 price point establishes a clear valuation level where institutional supply meets demand.

Additional Context

Transaction Notes

  • Multiple Entities: The sale was distributed across multiple holding vehicles (Carlyle Mozart, CP Circle entities, etc.) as detailed in Footnote 1.
  • Secondary Transaction: The filing also notes a "J" code transaction for 2.1 million shares, representing a pro-rata distribution to limited partners, further dispersing stock into the market.
Topics:#Medline#MDLN#CarlyleGroup#InsiderSelling#HighSignificance#Form4#StockMarket#PrivateEquity#BlockTrade#SECFiling

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.